Clinical Trials Browser

Interventional × Urethral Neoplasms × Sorafenib × Clear all

NCT01844947 2019-04-26

VINSOR

Phase 1 Completed

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms, Urethral Neoplasms

NCT00112905 2014-05-30

Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium

Phase 2 Terminated

27 enrolled 8 charts

Urinary Bladder Neoplasms, Urethral Neoplasms